Telomir PharmaceuticalsTELO
13F holders, Q3 2025 (September 30)32holders −11
6new positions
17sold out
1famous investor
$1.39avg. 13F price*
At the end of Q3 2025, 32 institutions reported holding Telomir Pharmaceuticals Inc. (TELO) in their 13F filings, down 11 from Q2 2025. 6 opened new positions and 17 sold out. The largest holders were Vanguard Group Inc. ($1.5M), BlackRock, Inc. ($405K) and Millennium Management ($309K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Telomir Pharmaceuticals Inc.
- CUSIP
- 87975F104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $103K |
| Exits | 17 | $368K |
All 13F filers, Q2 2025 → Q3 2025: 175,407 shares bought and 651,065 shares sold, net −475,658 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Vanguard Group Inc. | 0.00% | Reduce -1.5% | 1,101,752 | $1.5M |
| BlackRock, Inc. | 0.00% | Reduce -21.3% | 291,433 | $405K |
| Millennium Management | 0.00% | Reduce -10.2% | 222,404 | $309K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.4% | 196,030 | $273K |
| Raymond James Financial Inc. | 0.00% | Add +4101.9% | 75,340 | $105K |
| UBS Group AG | 0.00% | Add +30.4% | 63,536 | $88K |
| State Street Corp. | 0.00% | Reduce -4.9% | 58,600 | $81K |
| Bank of New York Mellon Corp | 0.00% | Add +0.0% | 51,454 | $72K |
| Suncoast Equity Management | 0.01% | No change | 51,194 | $71K |
| Northern Trust Corp. | 0.00% | No change | 41,844 | $58K |
| Osaic Holdings, Inc. | 0.00% | Add +16.9% | 24,510 | $33K |
| OneDigital Investment Advisors LLC | 0.00% | Add +64.3% | 23,000 | $32K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -85.9% | 22,636 | $31K |
| Praetorian Wealth Management, Inc. | 0.01% | New | 20,000 | $28K |
| Mariner, LLC | 0.00% | New | 19,994 | $28K |
| Jane Street Group, LLC | 0.00% | Reduce -60.1% | 19,775 | $27K |
| Clearstead Advisors, LLC | 0.00% | New | 12,530 | $17K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -58.5% | 11,015 | $15K |
| Kestra Private Wealth Services, LLC | 0.00% | New | 11,000 | $15K |
| Regions Financial Corp. | 0.00% | New | 10,638 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -85.5% | 1,251 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -36.5% | 599 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 600 | $834 |
| EverSource Wealth Advisors, LLC | 0.00% | Add +723.9% | 379 | $527 |
| BNP Paribas Financial Markets | 0.00% | Reduce -72.5% | 347 | $482 |
| Morgan Stanley | 0.00% | Reduce -98.7% | 334 | $464 |
| Bank of America Corp. | 0.00% | Reduce -99.7% | 23 | $32 |
| Arax Advisory Partners | 0.00% | New | 9 | $12 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $6 |
| Barclays PLC | 0.00% | Reduce -99.9% | 2 | $3 |
| Citigroup Inc. | 0.00% | Reduce -100.0% | 1 | $1 |
| Cwm, LLC | 0.00% | Reduce -99.9% | 2 | $0 |
"% of holder's portfolio" is TELO's weight in each manager's 13F, not the share of Telomir Pharmaceuticals Inc. the manager owns.